Storage And Transportation; Specifications - Ambu VivaSight Bedienungsanleitung

• Do not use VivaSight EBB if the cuff is
damaged. Care must be taken to avoid
damaging the cuff during use.
• The cuff pressure should not exceed
20 cm H₂O. Diffusion of a nitrous oxide
mixture, oxygen, or air may either
increase or decrease the cuff pressure.
• Do not overinflate the cuff. Overinflation
can result in tracheal damage, rupture
of the cuff with subsequent deflation,
or cuff distortion, which may lead to
airway blockage.
• Make sure to insert the blocker's tip
within the VivaSight 2 SLT or equivalent
before connecting the multi joint
connector on the blocker to VivaSight 2
SLT or equivalent 15mm connector to
avoid pulling the tip back in the multijoint
connector.
CAUTIONS
• VivaSight EBB is intended for use by
trained personnel only.
• Use a water-soluble lubricant only. Other
lubricants might affect the cuff.
• The use of lidocaine topical aerosols
has been associated with the formation
of pinholes in PVC cuffs*. To prevent cuff
leaks, expert clinical judgment is required
when using lidocaine topical aerosols.
*Jayasuriya KD, Watson WF: "P.V.C. cuffs
and Lidocainebased aerosol"; Br J Anaesth.
1981 Dec; 53 (12): 1368.
• Use a cuff pressure gauge to help monitor
and adjust the cuff pressure. inflation of
the cuff by "feel" alone or by using a
measured volume of air is not recommended
as resistance is an unreliable guide during
inflation.
• Syringes, stopcocks, or other devices
should not be left in the inflation system
for an extended period.
STORAGE AND
TRANSPORTATION
• Store and transport VivaSight EBB at
temperatures between -15° C and 49° C,
relative humidity between 10-100% and
atmospheric pressure between 80-109 kPa.
• Store in a dry, cool and dark place.
ADVERSE EVENTS
Reported adverse reactions associated
with the use of endobronchial blockers
are many and diverse. Adverse events
associated with the use of VivaSight EBB
are the same as those for standard
endobronchial blockers. Potential
adverse events related to endobronchial
blockers include perforating a bronchus
or lung parenchyma, causing pneumo-
thorax; mistakenly inflating the bronchial
cuff near the tracheal lumen, producing
respiratory arrest; developing severe
hypoxemia and potential pulmonary
edema following continuous suctioning of
the nondependent lung by the blocker.

SPECIFICATIONS

• Size: 9 Fr
• Tube length: up to 700 mm
• Compatible for use with VivaSight 2 SLT
or equivalent endotracheal
tube with inner diameter (mm): 7.0, 7.5, 8.0
• Operating ambient temperature:10-37 °C
(50-98 °F)
• Operating relative humidity: 30-75%
• Operating atmospheric pressure: 80-109 kPa
• Operating altitude: ≤2000 m
BEFORE PLACEMENT
If you are intubating with VivaSight 2
SLT follow VivaSight 2 SLT Instructions
For Use (IFU).
Note:
Do not use if VivaSight EBB's sterile
(ETO) package has been damaged or
previously opened.
1. Test the cuff for integrity by completely
inflating and deflating prior to use.
a. For proper inflation, cuff pressure
should not exceed 20 cm H₂O.
b. For proper deflation, use a 20 cc
syringe to completely deflate the cuff.
c. Pull the syringe plunger back towards
the 20 cc mark.
d. Disconnect the syringe from the
inflation port without releasing the
plunger.
2. Prepare the patient.
3. Lubricate the entire surface of
VivaSight EBB's cuff and the interior
surface of VivaSight 2 SLT or equivalent.
- 4 -